Ultratech Cement Ltd.
NSE: ULTRACEMCO
Basic Materials · Building Materials
₹11,050.00 last close on 23 Oct 2026 +0.84%
Research updated
Sumitomo Chemical India Ltd.
NSE: SUMICHEMBasic MaterialsAgricultural Inputs
- Last close
- ₹360.60
- Day change
- −₹9.90 (−2.67%)vs
- Market cap
- ₹20,203 crIndian rupees
- Research updated
- 1 report
Follow Sumitomo Chemical India
Create an account, then follow this company for weekday briefs. You will return to Sumitomo Chemical India after signing in.
About Sumitomo Chemical India
Sumitomo Chemical India Ltd. is a prominent player in the agrochemical industry, operating under the broader umbrella of Sumitomo Chemical Co., Ltd., a Japanese global chemical conglomerate. This company is primarily engaged in the manufacture and distribution of a wide array of products catering to the agricultural sector, including insecticides, fungicides, herbicides, and plant growth regulators, which are crucial for crop protection and enhancement. Sumitomo Chemical India Ltd. serves a vast clientele, comprising farmers, agricultural enterprises, and governmental bodies, playing a pivotal role in boosting agricultural productivity and sustainability. The company is known for its commitment to innovation, with a strong emphasis on research and development to create products that are both effective and environmentally friendly. With India's agriculture-based economy, Sumitomo Chemical India Ltd. holds a significant position in promoting modern agricultural practices and ensuring food security. The company's operations are integral to the country's efforts in improving agricultural yields and safeguarding crops against pests and diseases, highlighting its substantial market presence and influence.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Listing
- NSE: SUMICHEM
- Next results
- Employees
- 1,622
- Headquarters
- Mumbai, India
- ISIN
- INE258G01013
- Website
- sumichem.co.in
Public research · Report of
Business model & financial foundation
Sumitomo Chemical India (NSE: SUMICHEM), Agricultural Inputs: revenue of ₹3,238 crore in FY26 (+2.9% on FY25), an EBITDA margin of 20.7%, net profit of ₹543.0 crore and net cash of ₹2,050 crore.
- Revenue, FY26 (₹ crore)
- 3,238
- consolidated
- Revenue growth, FY26
- +2.9%
- on FY25
- EBITDA margin, FY26
- 20.7%
- EBITDA (Company operating EBITDA excluding other income) / revenue
- Net profit, FY26 (₹ crore)
- 543.0
- to owners
- Return on equity, FY26
- 17.2%
- on average equity
- Net debt, FY26 (₹ crore)
- -2,050
- Debt including leases less broad treasury liquidity (approximate)
- Market capitalisation (₹ crore)
- 22,664
- at the close of 16 Oct 2026
Company profile
| Item | Value |
|---|---|
| Legal name | Sumitomo Chemical India Limited |
| Exchange and ticker | NSE: SUMICHEM; BSE: 542920 |
| ISIN | INE258G01013 |
| CIN | L24110MH2000PLC124224 |
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| Headquarters | Mumbai, India |
| Fiscal year end | March |
| Reporting basis and unit | consolidated, in ₹ crore |
| Auditor | B S R & Co. LLP (since FY25) |
| Market capitalisation | ₹22,664 crore (16 Oct 2026) |
| Shares outstanding | 49.91 crore shares (FY26) |
| Price | ₹404.9 (close, 16 Oct 2026) |
| 52-week range | ₹362.6 - ₹572.0 (to 16 Oct 2026) |
| Website | https://sumichem.co.in |
Corporate structure and shareholding
Parent: Sumitomo Chemical Company, Limited, Japan.
| Entity | Holding | Business |
|---|---|---|
| Barrix Agro Sciences Private Limited | 85% | Integrated pest and plant nutrition management, biological traps |
| Excel Crop Care (Africa) Limited | 99.94% | Tanzania; voluntary winding up |
Excel Crop Care India merged into SCIL in August 2019; not a current subsidiary.
| Shareholding (% of shares) | Q3FY26 | Q4FY26 | Q1FY27 | Q2FY27 |
|---|---|---|---|---|
| Promoter | 75.00% | 75.00% | 75.00% | 75.00% |
| Promoter holding pledged | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign institutions | 3.37% | 3.40% | 3.02% | 2.89% |
| Domestic institutions | 8.65% | 8.98% | 9.33% | 9.69% |
| of which mutual funds | 6.53% | 6.88% | 7.27% | 7.68% |
| Retail | 6.39% | 6.27% | 6.28% | 6.16% |
| Other | 6.58% | 6.35% | 6.37% | 6.26% |
The promoter holding pledged is a share of the promoter's own holding.
Business model
Sumitomo Chemical India (SCIL) makes and sells crop protection formulations and technicals: insecticides (41% of FY26 sales), herbicides (24%), PGR (10%), metal phosphides (8%), fungicides (8%) and animal nutrition/environmental health (9%). Its 75% parent, Sumitomo Chemical Japan, supplies proprietary molecules and is both a supplier (FY26 purchases INR 333.8cr) and a customer (sales INR 136.6cr). In FY26 India was INR 2,535.8cr of geographic revenue and outside India INR 673.1cr; another INR 29.4cr was other operating revenue. Demand follows the monsoon: about 60% of revenue comes in the first half. The company is net cash, with about INR 2,113cr of liquid investments at Mar-26, and is rated CRISIL AA/Stable.
| Peer | Why the dossier compares them |
|---|---|
| PI Industries (PIIND) | Custom synthesis and differentiated agrochemistry |
| Bayer CropScience (BAYERCROP) | MNC proprietary domestic crop protection portfolio |
| Dhanuka Agritech (DHANUKA) | Branded domestic crop protection distribution |
| Rallis India (RALLIS) | Domestic crop protection and manufacturing |
| Sharda Cropchem (SHARDACROP) | Export agrochemicals, asset-light registration portfolio |
Financial databook
| Profit and loss (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,036 | 3,473 | 2,844 | 3,149 | 3,238 |
| Cost of revenue (vendor classification) * | 1,924 | 2,285 | 1,799 | 1,883 | 1,904 |
| Other operating costs (vendor classification) * | 298.2 | 305.0 | 276.1 | 316.0 | 280.5 |
| EBITDA (vendor classification) * | 610.1 | 693.6 | 549.9 | 715.2 | 815.4 |
| Operating EBIT excluding other income | 580.5 | 658.0 | 412.4 | 566.0 | 604.7 |
| Finance cost including lease interest | 4.72 | 3.85 | 5.11 | 5.86 | 7.83 |
| Profit before tax | 575.7 | 654.2 | 502.9 | 680.2 | 727.6 |
| Tax | 152.2 | 152.0 | 133.2 | 173.8 | 184.6 |
| PAT including non-controlling interests | 423.6 | 502.2 | 369.7 | 506.4 | 543.0 |
| Diluted EPS (₹) | 8.49 | 10.06 | 7.40 | 10.13 | 10.88 |
| Materials, traded goods and inventory change | 1,775 | 1,859 | 1,877 | ||
| Employee benefits expense | 232.0 | 264.7 | 273.8 | ||
| Other operating expenses | 362.3 | 392.9 | 416.3 | ||
| Company operating EBITDA excluding other income | 474.6 | 632.1 | 670.9 | ||
| Other income | 95.7 | 120.1 | 146.7 | ||
| Depreciation and amortisation | 62.2 | 66.1 | 66.1 | ||
| Exceptional gain positive; expense negative | 0.00 | 0.00 | -16.1 | ||
| PAT attributable to owners | 369.5 | 505.5 | 543.0 | ||
| PAT attributable to non-controlling interests | 0.20 | 0.95 | 0.01 |
| Balance sheet (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Total equity | 1,927 | 2,382 | 2,445 | 2,905 | 3,394 |
| Total debt including lease liabilities | 37.6 | 34.0 | 30.2 | 51.9 | 63.3 |
| Cash and cash equivalents only | 57.3 | 46.9 | 46.6 | 38.2 | 68.9 |
| Trade receivables | 843.1 | 946.1 | 715.9 | 783.4 | 735.6 |
| Inventories | 937.8 | 888.7 | 610.4 | 703.7 | 766.1 |
| Trade payables | 517.2 | 490.2 | 430.0 | 489.4 | 397.1 |
| Net fixed assets: PPE, ROU and other intangible assets | 500.3 | 495.9 | 516.3 | ||
| Capital work in progress excluding IAUD | 21.1 | 53.5 | 3.97 | 9.36 | 2.53 |
| Total assets | 3,010 | 3,369 | 3,313 | 3,964 | 4,474 |
| Property, plant and equipment excluding ROU | 451.7 | 425.8 | 437.3 | ||
| Debt including leases less broad treasury liquidity (approximate) | -1,176 | -1,616 | -2,050 |
| Cash flow (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Net cash generated from operating activities | 391.2 | 524.2 | 757.2 | 451.5 | 445.5 |
| Free cash flow (vendor definition) * | 108.3 | 269.5 | 693.4 | 422.1 | 401.3 |
| Dividends paid; signed cash outflow | -40.0 | -49.9 | -309.8 | -44.0 | -59.9 |
| Purchase PPE including capital advances; positive cash outflow | -112.5 | -119.5 | 63.7 | 29.5 | 44.2 |
| Free cash flow: CFO less cash capex | 693.4 | 422.0 | 401.3 |
| Other reported lines (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Issued ordinary shares (constant) | 49.91 | 49.91 | 49.91 | 49.91 | 49.91 |
| Company broad liquid balances (approximate) | 1,668 | 2,113 | |||
| AR gross treasury components excluding accrued interest | 1,207 | 1,670 | 2,122 | ||
| Alternative net debt using AR gross treasury components | -1,176 | -1,618 | -2,058 |
| Quarterly profit and loss (₹ crore) | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 988.3 | 641.9 | 679.4 | 1,057 | 929.8 | 568.0 | 683.7 | 1,063 |
| Cost of revenue (vendor classification) * | 567.6 | 371.4 | 407.5 | 654.4 | 299.0 | 394.8 | 646.6 | |
| Other operating costs (vendor classification) * | 109.3 | 96.1 | 87.7 | 112.4 | 104.1 | 86.7 | 110.2 | |
| EBITDA (vendor classification) * | 276.5 | 137.4 | 151.2 | 258.0 | 136.4 | 166.4 | 280.6 | |
| Operating EBIT excluding other income | 229.6 | 87.1 | 103.1 | 203.5 | 201.3 | 82.7 | 117.3 | 216.1 |
| Finance cost | 1.22 | 1.79 | 1.66 | 1.66 | 2.24 | 2.02 | 1.91 | 2.00 |
| Profit before tax | 259.6 | 116.5 | 133.1 | 240.6 | 237.8 | 101.6 | 147.6 | 288.2 |
| Tax | 67.0 | 29.1 | 33.3 | 62.5 | 60.1 | 25.8 | 36.2 | 73.7 |
| PAT including non-controlling interests | 192.5 | 87.4 | 99.8 | 178.1 | 177.8 | 75.8 | 111.3 | 214.5 |
| Diluted EPS (not annualised) (₹) | 3.85 | 1.74 | 2.00 | 3.57 | 3.56 | 1.52 | 2.23 | 4.30 |
| Materials, traded goods and inventory change | 567.6 | 371.4 | 407.5 | 654.4 | 529.2 | 298.9 | 394.8 | 646.6 |
| Company operating EBITDA excluding other income | 245.3 | 106.1 | 119.6 | 219.2 | 218.0 | 99.5 | 134.2 | 233.3 |
| Other operating expenses | 109.3 | 96.1 | 87.7 | 112.3 | 113.0 | 104.1 | 86.7 | 110.2 |
| Employee benefits expense | 66.1 | 68.3 | 64.7 | 70.8 | 69.5 | 65.4 | 68.0 | 73.2 |
| Other income | 31.2 | 31.2 | 31.6 | 38.8 | 38.8 | 37.0 | 32.2 | 47.3 |
| Depreciation and amortisation | 15.7 | 19.1 | 16.4 | 15.7 | 16.8 | 16.7 | 16.9 | 17.2 |
| Exceptional gain positive; expense negative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -16.1 | 0.04 | 26.9 |
| PAT attributable to owners | 192.3 | 87.0 | 99.6 | 178.3 | 177.8 | 75.6 | 111.2 | 214.8 |
| PAT attributable to non-controlling interests | 0.25 | 0.48 | 0.20 | -0.24 | -0.00 | 0.17 | 0.09 | -0.32 |
Consolidated, as reported. Lines marked * are the market-data provider's figures; the rest are extracted from the company's filings or derived from them. n.d. not disclosed, n.r. not retrieved, n.a. not applicable.
Metrics dashboard
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue growth | 15.7% | 14.4% | -18.1% | 10.7% | 2.9% |
| EBITDA margin | 16.7% | 20.1% | 20.7% | ||
| Net margin | 13.0% | 16.1% | 16.8% | ||
| Return on equity | 15.3% | 18.9% | 17.2% | ||
| Return on capital employed | 32.8% | 30.0% | 16.9% | 20.8% | 18.9% |
| Return on assets | 11.1% | 13.9% | 12.9% | ||
| Net debt (₹ crore) | -1,176 | -1,616 | -2,050 | ||
| Net debt / EBITDA | -2.48x | -2.56x | -3.06x | ||
| Interest cover | 123.0x | 170.9x | 80.7x | 96.6x | 77.3x |
| Asset turnover | 1.07x | 1.09x | 0.85x | 0.87x | 0.77x |
| Receivable days | 101 | 99 | 92 | 91 | 83 |
| Inventory days (on revenue) | 113 | 93 | 78 | 82 | 86 |
| Payable days (on revenue) | 62 | 52 | 55 | 57 | 45 |
| Cash conversion | 2.05x | 0.89x | 0.82x | ||
| Capex intensity | 3.7% | 3.4% | 2.2% | 0.9% | 1.4% |
| Free cash flow (₹ crore) | 278.8 | 404.7 | 693.4 | 422.0 | 401.3 |
| Dividend payout | 83.8% | 8.7% | 11.0% | ||
| EPS, diluted (₹) | 8.49 | 10.06 | 7.40 | 10.13 | 10.88 |
| Book value per share (₹) | 38.61 | 47.72 | 48.97 | 58.20 | 67.99 |
Computed from the statements above:
- Revenue growth: revenue over the previous year's, less one.
- EBITDA margin: EBITDA (Company operating EBITDA excluding other income) / revenue.
- Net margin: net profit to owners / revenue.
- Return on equity: net profit to owners / average equity.
- Return on capital employed: EBIT / average equity plus borrowings.
- Return on assets: net profit to owners / average total assets.
- Net debt (₹ crore): Debt including leases less broad treasury liquidity (approximate); negative is net cash.
- Net debt / EBITDA: net debt / EBITDA (Company operating EBITDA excluding other income).
- Interest cover: EBIT / finance cost.
- Asset turnover: revenue / average total assets.
- Receivable days: receivables / revenue x 365.
- Inventory days (on revenue): inventory / revenue x 365.
- Payable days (on revenue): payables / revenue x 365.
- Cash conversion: cash from operations / net profit to owners.
- Capex intensity: capital expenditure / revenue.
- Free cash flow (₹ crore): cash from operations less capital expenditure.
- Dividend payout: dividends paid / net profit to owners.
- EPS, diluted (₹): as reported (Diluted EPS).
- Book value per share (₹): equity / shares outstanding.
Source: the company's filings and disclosures as extracted into Mool's company dossier (version 1, information to 16 Oct 2026); market data at the close of 16 Oct 2026. Every figure is read from the dossier's files or computed from them; the account of the business model is the analyst's, from the dossier's workings.
With Individual or above
What the full research on Sumitomo Chemical India includes
Every piece of Mool’s research is built the same way: a researched evidence base, analyses that build on each other, a research model and a report with the call. This page shows the first analysis.
The report and Mool’s call
- The 12-month rating and target
- The 3-month view
- Mool's estimates beside the street's
- The claims the view rests on, and what would change it
The analyses, among them
- Business model & financial foundationOn this pageWhat the company does and how it makes money, its structure, five years of financials and the metrics that matter for it.
- Future earnings & financial modelForecasts built from the drivers that move the business, by scenario, beside the street's.
- Fundamental valuation & 12-month thesisWhat the business is worth on several methods, what the market already prices in and the 12-month thesis that follows.
The research model
The model behind the report: the company’s history, the drivers that move it, its forecasts by scenario and the valuation the 12-month target comes from.
See Mool’s call and the full research
Individual or above opens every piece of research Mool has published. A new account can start with 10 days of Pro, or of Firm on a work email address. No card needed.
Report history
Reports on Sumitomo Chemical India
- Research reportLatest
Same sector
More research in Basic Materials
JSW Steel Ltd.
NSE: JSWSTEEL
Basic Materials · Steel
₹1,185.50 last close on 23 Oct 2026 −2.83%Research updated
Asian Paints Ltd.
NSE: ASIANPAINT
Basic Materials · Specialty Chemicals
₹2,307.00 last close on 23 Oct 2026 +0.97%Research updated
Hindustan Zinc Ltd.
NSE: HINDZINC
Basic Materials · Other Industrial Metals & Mining
₹496.00 last close on 23 Oct 2026 −4.25%Research updated
Tata Steel Ltd.
NSE: TATASTEEL
Basic Materials · Steel
₹167.67 last close on 23 Oct 2026 −2.70%Research updated
Hindalco Industries Ltd.
NSE: HINDALCO
Basic Materials · Aluminum
₹869.85 last close on 23 Oct 2026 −1.78%Research updated
Prices are the last close on the NSE, 23 Oct 2026. Research from Mool’s report of 16 Oct 2026; page updated 25 Oct 2026.
Mool’s research is written by AI agents and published by Mool Capital Private Limited, a SEBI-registered Research Analyst, registration INH000012449, which is responsible for it. This page shows factual company information and an excerpt of that research; it carries no rating and is not investment advice for any individual. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Read the disclosures.